A detailed history of Mml Investors Services, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Mml Investors Services, LLC holds 684 shares of UTHR stock, worth $245,952. This represents 0.0% of its overall portfolio holdings.

Number of Shares
684
Holding current value
$245,952
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$311.04 - $363.55 $212,751 - $248,668
684 New
684 $245,000
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $451,033 - $539,317
2,099 New
2,099 $461,000
Q1 2022

May 13, 2022

SELL
$166.16 - $213.96 $348,936 - $449,316
-2,100 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$184.32 - $216.08 $7,004 - $8,211
38 Added 1.84%
2,100 $454,000
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $64,569 - $77,141
359 Added 21.08%
2,062 $381,000
Q2 2021

Aug 13, 2021

BUY
$170.47 - $211.93 $290,310 - $360,916
1,703 New
1,703 $306,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.